Valneva Announces US FDA Approval of Chikungunya Vaccine IXCHIQ
Released: Friday 10th November 2023
Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ
For full details please click here.
The voice of Scotland's life sciences industries
- BioAscent reports promising growth as it marks tenth anniversary
- EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials
- Medannex Strengthens Global Intellectual Property Portfolio for Novel Clinical Asset
- BioAscent invests in new state-of-the-art protein production facility
- US investment set to open doors for leading Dundee biotechnology company
- All Members' News
© Scottish Lifesciences Association 2024
Scottish Lifesciences Association, 44 Charlotte Square, Edinburgh, EH2 4HQ, Scotland
Registered in Scotland - SC390602
Tel: +44 (0) 7753 312 263
